<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (IIH, <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>) was diagnosed in 4 patients who had been treated with <z:chebi fb="9" ids="27902">tetracycline</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The main symptom was <z:hpo ids='HP_0002315'>headache</z:hpo>, and in <z:hpo ids='HP_0000001'>all</z:hpo> there was <z:hpo ids='HP_0001085'>papilledema</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Symptoms and signs improved after <z:chebi fb="9" ids="27902">tetracycline</z:chebi> was discontinued and <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> treatment started </plain></SENT>
<SENT sid="3" pm="."><plain>When a patient receiving <z:chebi fb="9" ids="27902">tetracycline</z:chebi> develops IIH, the medication should be stopped as it may be the cause of the IIH, as appeared to be the case in our 4 patients </plain></SENT>
</text></document>